What Oncology and Hematology Fellows Can Do to Reduce Their Loan Debt
While debt from medical school loans is inevitable for most oncology and hematology fellows, there are strategies they can consider to lessen that burden.
Loan Repayment Programs for Oncology/Hematology Fellows
Itâ€™s no surprise that you acquire significant debt during your medical training. Here are some ways to get those loans paid off.
Emerging Cancer Vaccines Appear to Be on Track for Major Advances
Both industry and clinical sources agree that cancer vaccine research is finally on the right track to achieve major advances in treatment.
Crisis Averted? Manufacturers Scurry to Meet Demand for Drugs
The shortage, which began in 2009, accelerated in 2010, and has shown no signs of abatement so far in 2011, according to Erin R. Fox, PharmD, manager of the Drug Information Service at University of Utah Health Care
Later-Line Ruxolitinib Use Produces Ongoing Benefit in Real-World Patients With cGVHD
Orca-T Data With Survival, Tolerability Extends to Older Patients With Hematologic Cancers
Dr Ramdial on Gemcitabine/Clofarabine/Busulfan for Lymphoma Stem Cell Transplant
Retrospective Analysis Shows Post-HCT Survival Benefits With Orca-T Vs PTCy in Hematologic Malignancies
2 Commerce Drive Cranbury, NJ 08512